ChemAbout
© 2026 ChemAbout
Insights|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/Neomycin EP Impurity G
C25H48N6O14
656.7 g/mol
Pharmaceutical Intermediate

Neomycin EP Impurity G

CAS54631-94-6
Category
Pharmaceutical Intermediate
Compound Class
Other
Primary Use
Pharmaceutical Intermediate

Neomycin EP Impurity G is a defined chemical compound used as a reference standard in pharmaceutical quality control. It is a structurally complex aminoglycoside derivative related to the antibiotic neomycin.

Pharmaceutical impurity reference standard for analytical testingQuality control standard in neomycin drug substance analysisResearch reagent for impurity profiling studies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing or supplying this compound?

List your inventory or post a purchase request

CAS 54631-94-6

List This Product
Sign in to publish supply information
Request This Product
Submit a request without registering

Related Compounds

SimilarStructure SimilarSimilarity 0.76

3-Acetylneamine

CAS54617-39-9

pharmaceutical intermediate

ReferenceSame Category

(6R,7R)-3-Hydroxy-8-oxo-7-[(phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid diphenyl methyl ester

CAS54639-48-4

pharmaceutical intermediate

ReferenceSame Category

6-chloro-4-(O-chlorophenyl)-2-quinazolinecarboxylic acid

CAS54643-79-7

pharmaceutical intermediate

ReferenceSame Category

Aminoacetonitrile sulfate

CAS5466-22-8

pharmaceutical intermediate

ReferenceSame Category

4,6-Dihydroxynicotinic acid

CAS5466-62-6

pharmaceutical intermediate

Referencesame scaffold

Neomycin c

CAS66-86-4

pharmaceutical raw material

Referencesame scaffold

Neomycin

CAS1404-04-2

pharmaceutical raw material

Referencesame scaffold

Neomycin sulfate

CAS1405-10-3

pharmaceutical raw material

Identifiers
IUPAC Name

N-[(1S,2R,3R,4S,5R)-5-amino-2-[(2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4-hydroxycyclohexyl]acetamide

InChIKey

GDIGCFFRSPUIEB-ZDKLCTEPSA-N

SMILES

CC(=O)N[C@H]1C[C@H]([C@@H]([C@H]([C@@H]1O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N

Synonyms (3)
  • Framycetin Sulfate EP Impurity G; Neomycin Sulfate EP Impurity G
  • Neomycin EP Impurity G